Sentence examples for model structures at from inspiring English sources

Open image in new window Fig. 16 Plastic hinge formation in the model structures at the maximum inter-story drift ratio of 2.5%.

Particularly, deep model structures at the fine-tuning stage are only different in the last fully connected layer for predicting labels.

Figure 16 depicts the plastic hinge formation in the model structures at the maximum inter-story drift of 2.5% of the story height.

However the major drop of strength occurs as a result of yield of the 4th story beam, and the residual strength is larger than that of the model SD. Figure 15 depicts the maximum inter-story drifts of the model structures at the point of the maximum strength and at the maximum inter-story drift of 2.5% obtained from pushover analysis.

It can be observed that the maximum roof drift of the model structure at the major strength drop is significantly smaller than that of the structure at the maximum allowable inter-story drift of 2.5%.

A new molecular model is created incorporating these new ideas along with the new extensional rheometry experimental results of Auhl et al. into the polydisperse MLD model structure at the "toy" level [1 4].

Therefore, developing continuum models which may overcome these restrictions are expected to be the dominant tool for modeling structures at the scale of nanometers and performing analytical analysis of CNTs of larger scales.

Under the US DOE Advanced Computing initiatives (first the Grand Challenge and now SciDAC), SLAC has developed a suite of electromagnetic codes based on unstructured grids and utilizing high-performance computing to provide an advanced tool for modeling structures at accuracies and scales previously not possible.

Importantly, as some of the examples in Figure 4 highlight, there is often uncertainty surrounding the true N- and C-termini of genes and most of the variability in the gene model structures exists at these regions.

However, evaluations of the cost-effectiveness of celecoxib have produced conflicting results owing mainly to differences in model structures, populations at risk, probabilities, cost-effectiveness indicators, and relative drug prices across countries.

4, 5 and 6, model structures do not appear at all.